From f114b4eb1e8a9adf21ca98d8f6bbea878ae5b2c6 Mon Sep 17 00:00:00 2001 From: Borja Robert Date: Mon, 11 Mar 2024 10:25:03 +0100 Subject: [PATCH] Auto saved by Logseq --- pages/STOP2030___Web___Posts.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/pages/STOP2030___Web___Posts.md b/pages/STOP2030___Web___Posts.md index e04d2569..4fea43fa 100644 --- a/pages/STOP2030___Web___Posts.md +++ b/pages/STOP2030___Web___Posts.md @@ -4,6 +4,6 @@ - ## Our first, and biggest, clinic trial is registered - #+BEGIN_VERSE At STOP2030 we want to provide a pharmacological tool that helps at delivering WHO's goals for soil-transmitted helminthiasis (STH). That is why we're happy to announce that the REALISE study (Real world Evaluation of an ALbendazol-Ivermectin coformulation Safety and Effectiveness), our most ambitious clinical trial, has been approved for publication in clinicaltrials.gov and the Pan African Clinical Trial Registry. - This clinical trial is a Cohort Event Study aimed at evaluating both the safety and effectiveness of our fixed-dose coformulation of albendazol and ivermectin within large populations, matched against single dose albendazole, We expect to recruit around 20 thousand people. + This clinical trial is a Cohort Event Study aimed at evaluating both the safety and effectiveness of our fixed-dose coformulation of albendazol and ivermectin within large populations, matched against the standard dose albendazole , We expect to recruit around 20 thousand people. #+END_VERSE \ No newline at end of file